Casi Pharmaceuticals Inc (CASI)
2.20 x 19 3.00 x 11
Post-market by (Cboe BZX)
2.30 unch (unch) 03/20/25 [NASDAQ]
2.20 x 19 3.00 x 11
Post-market 2.30 unch (unch) 14:31 ET
for Thu, Mar 20th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 33,879 | 43,107 | 30,168 | 15,141 | 4,131 |
| Cost of Goods | 13,827 | 15,827 | 12,557 | 9,508 | 3,935 |
| Gross Profit | 20,052 | 27,280 | 17,611 | 5,633 | 196 |
| Operating Expenses | 45,959 | 62,139 | 59,684 | 58,922 | 48,089 |
| Operating Income | -25,080 | -34,032 | -41,516 | -52,781 | -46,958 |
| Other Income | -1,260 | -4,245 | 5,674 | 5,270 | 1,596 |
| Pre-tax Income | -26,340 | -38,277 | -35,842 | -47,511 | -45,362 |
| Income Tax | -81 | 1,980 | N/A | N/A | N/A |
| Net Income Continuous | -26,259 | -40,257 | -35,842 | -47,511 | -45,362 |
| Minority Interests | 679 | 757 | 812 | 776 | 670 |
| Net Income | $-26,938 | $-41,014 | $-36,654 | $-48,287 | $-46,032 |
| EPS Basic Total Ops | -2.02 | -3.01 | -2.69 | -4.37 | -4.80 |
| EPS Basic Continuous Ops | -1.97 | -2.95 | -2.63 | -4.30 | -4.73 |
| EPS Diluted Total Ops | -2.02 | -3.01 | -2.69 | -4.37 | -4.80 |
| EPS Diluted Continuous Ops | -1.97 | -2.95 | -2.63 | -4.30 | -4.73 |
| EPS Diluted Before Non-Recurring Items | -1.86 | -3.01 | -2.60 | -4.30 | -4.20 |
| EBITDA(a) | $-21,339 | $-31,610 | $-39,701 | $-50,822 | $-44,805 |